Much ado about much: Stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis

OBJECTIVES In the context of a stress-vulnerability framework, hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis is thought contribute to the risk, onset and course of psychotic illness. However, recent reports regarding static and dynamic features of the HPA axis suggest a more complex set of phenomena at play in the early phases of psychosis. METHODS We review literature regarding structural and functional aspects of the HPA axis in subjects at risk for or experiencing the first episode of psychosis, including evidence favoring as well as that which contradicts a model of HPA axis hyperactivation. RESULTS Static measures of diurnal cortisol and hippocampal/pituitary volumes suggest that the HPA axis is in a hyperactivated state in early phases of psychosis. In contrast, the dynamic cortisol response to encountered or anticipated stress is blunted in the same populations. These incongruent findings need to be better understood. CONCLUSIONS We consider potential explanations for the seemingly contradictory elevation and blunting of HPA biomarkers in the early course of psychosis. Finally, we propose and explore implications of a conceptual model of tonic HPA hyperactivation and phasic HPA blunting that integrates and reconciles these data.

[1]  C. Pariante Pituitary volume in psychosis: the first review of the evidence , 2008, Journal of psychopharmacology.

[2]  E. Walker,et al.  The stress cascade and schizophrenia: etiology and onset. , 2003, Schizophrenia bulletin.

[3]  C. Pariante,et al.  Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis , 2005, Biological Psychiatry.

[4]  M. Gunnar,et al.  Neuroendocrine measures in developmental research , 2007 .

[5]  D. Malaspina,et al.  Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis , 2012, Psychological Medicine.

[6]  Xiaohua Liu,et al.  Abnormality of glycometabolism related factors in non-psychotic offspring of schizophrenic patients , 2012, Psychiatry Research.

[7]  H. Moore,et al.  Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. , 2009, Archives of general psychiatry.

[8]  C. Wied Stress in schizophrenia: an integrative view. , 2000 .

[9]  V. Mondelli,et al.  A systematic review of the activity of the hypothalamic–pituitary–adrenal axis in first episode psychosis , 2013, Psychoneuroendocrinology.

[10]  G. Sugranyes,et al.  HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis. , 2012, Journal of psychiatric research.

[11]  J BELBEY,et al.  What is schizophrenia? , 1982, Schizophrenia bulletin.

[12]  B. McEwen,et al.  Child’s stress hormone levels correlate with mother’s socioeconomic status and depressive state , 2000, Biological Psychiatry.

[13]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[14]  J. Bremner,et al.  MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders , 2005, Molecular Psychiatry.

[15]  T. McGlashan,et al.  The psychosis high-risk state: a comprehensive state-of-the-art review. , 2013, JAMA psychiatry.

[16]  R. Kahn,et al.  Selective impairments in the stress response in schizophrenic patients , 2000, Psychopharmacology.

[17]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[18]  R. Heinssen,et al.  Prediction and prevention of psychosis in youth at clinical high risk. , 2012, Annual review of clinical psychology.

[19]  M. Pruessner,et al.  Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls , 2011, Schizophrenia Research.

[20]  L. Haan,et al.  Childhood bullying and the association with psychosis in non-clinical and clinical samples: a review and meta-analysis , 2012, Psychological Medicine.

[21]  D. Malaspina,et al.  HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia , 2012, Schizophrenia Research.

[22]  E. Walker,et al.  Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. , 2010, Journal of abnormal psychology.

[23]  Peter B. Jones,et al.  Increased Pituitary Volume in Antipsychotic-Free and Antipsychotic-Treated Patients of the Æsop First-Onset Psychosis Study , 2005, Neuropsychopharmacology.

[24]  U. Gschwandtner,et al.  Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study. , 2010, Journal of psychiatric research.

[25]  M. Maj,et al.  Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure , 2014, Psychiatry Research.

[26]  Wiepke Cahn,et al.  Brain volumes in relatives of patients with schizophrenia: a meta-analysis. , 2007, Archives of general psychiatry.

[27]  L. Phillips,et al.  Comparison of experiences of stress and coping between young people at risk of psychosis and a non-clinical cohort. , 2012, Behavioural and cognitive psychotherapy.

[28]  E. Rüther,et al.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects , 2006, Psychopharmacology.

[29]  R Fog,et al.  Schizophrenia Research , 2015 .

[30]  A. Malla,et al.  First-Episode Psychosis, Early Intervention, and Outcome: What Have We Learned? , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[31]  Bruce S. McEwen,et al.  Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses , 2013, Harvard review of psychiatry.

[32]  Peter B. Jones,et al.  Cannabis use and risk of psychotic or aff ective mental health outcomes: a systematic review , 2007 .

[33]  D. Wong,et al.  Association of Amphetamine-Induced Striatal Dopamine Release and Cortisol Responses to Psychological Stress , 2007, Neuropsychopharmacology.

[34]  Thomas R Insel,et al.  Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. , 2010, Schizophrenia bulletin.

[35]  M. Owen,et al.  Genetics of schizophrenia , 2005, Current Opinion in Behavioral Sciences.

[36]  C. Pantelis,et al.  Stress, the Hippocampus and the Hypothalamic-Pituitary-Adrenal Axis: Implications for the Development of Psychotic Disorders , 2006 .

[37]  R. Kahn,et al.  Blunted cortisol response to a psychosocial stressor in schizophrenia , 1998, Schizophrenia Research.

[38]  M. Keshavan,et al.  Pituitary volume in neuroleptic-naïve schizophrenia: A structural MRI study , 2007, Schizophrenia Research.

[39]  A. Schatzberg,et al.  The Roles of Glucocorticoid and Dopaminergic Systems in Delusional (Psychotic) Depression a , 1988, Annals of the New York Academy of Sciences.

[40]  L. Phillips,et al.  Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis. , 2011, Journal of psychiatric research.

[41]  J van Os,et al.  Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis , 2011, Psychological Medicine.

[42]  C. Fernyhough,et al.  A new look at the neural diathesis--stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations. , 2007, Schizophrenia bulletin.

[43]  C. Pariante,et al.  Stress abnormalities in individuals at risk for psychosis: A review of studies in subjects with familial risk or with “at risk” mental state , 2012, Psychoneuroendocrinology.

[44]  A. Schatzberg,et al.  A corticosteroid/dopamine hypothesis for psychotic depression and related states. , 1985, Journal of psychiatric research.

[45]  J. Os,et al.  Emotional reactivity to daily life stress in psychosis. , 2001, Archives of general psychiatry.

[46]  A. Ciampi,et al.  Cortisol response to a psychosocial stressor in schizophrenia: Blunted, delayed, or normal? , 2009, Psychoneuroendocrinology.

[47]  J. Thakore,et al.  Evidence of basal pituitary–adrenal overactivity in first episode, drug naïve patients with schizophrenia , 2004, Psychoneuroendocrinology.

[48]  A. Reiss,et al.  Stress Predicts Brain Changes in Children: A Pilot Longitudinal Study on Youth Stress, Posttraumatic Stress Disorder, and the Hippocampus , 2007, Pediatrics.

[49]  M. Egan,et al.  Schizophrenia, just the facts What do we know, how well do we know it? , 1988, Schizophrenia Research.

[50]  M. Keshavan,et al.  Is early intervention for psychosis feasible and effective? , 2012, The Psychiatric clinics of North America.

[51]  A. Young,et al.  Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function , 2011, Proceedings of the National Academy of Sciences.

[52]  B. Kudielka,et al.  Trier Social Stress Test , 2007 .

[53]  J. Pruessner,et al.  Blunted cortisol awakening response in men with first episode psychosis: Relationship to parental bonding , 2013, Psychoneuroendocrinology.

[54]  D. Diforio,et al.  Schizophrenia: a neural diathesis-stress model. , 1997, Psychological review.

[55]  I. Myin-Germeys,et al.  From Epidemiology to Daily Life: Linking Daily Life Stress Reactivity to Persistence of Psychotic Experiences in a Longitudinal General Population Study , 2013, PloS one.

[56]  Henry A. Nasrallah,et al.  Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology , 2008, Schizophrenia Research.

[57]  Tyrone D. Cannon,et al.  Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study , 2013, Biological Psychiatry.

[58]  Jim van Os,et al.  The environment and schizophrenia , 2010, Nature.

[59]  W. Schlotz,et al.  Daily Life Stress and the Cortisol Awakening Response: Testing the Anticipation Hypothesis , 2012, PloS one.

[60]  C. Pariante,et al.  Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: A systematic review and meta-analysis , 2013, Psychoneuroendocrinology.

[61]  L. Phillips,et al.  Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients , 2013, The Australian and New Zealand journal of psychiatry.

[62]  M. Keshavan,et al.  Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions , 2015, Development and Psychopathology.

[63]  A. Mackinnon,et al.  Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients , 2009, Schizophrenia Research.

[64]  A. Schatzberg,et al.  Dexamethasone increases plasma free dopamine in man. , 1984, Journal of psychiatric research.

[65]  J. Zubin,et al.  Vulnerability--a new view of schizophrenia. , 1977, Journal of abnormal psychology.

[66]  J. Os,et al.  Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress , 2010, Psychiatry Research: Neuroimaging.

[67]  O. Wolf,et al.  Blunted neuroendocrine stress reactivity in young women with eating disorders. , 2015, Journal of psychosomatic research.

[68]  G. Dunn,et al.  Emotional and symptomatic reactivity to stress in individuals at ultra-high risk of developing psychosis , 2011, Psychological Medicine.

[69]  Jens C. Pruessner,et al.  Stress regulation in the central nervous system: evidence from structural and functional neuroimaging studies in human populations - 2008 Curt Richter Award Winner , 2010, Psychoneuroendocrinology.

[70]  Swaran P Singh,et al.  Early intervention in psychosis , 2010, British Journal of Psychiatry.

[71]  P. Gold,et al.  The organization of the stress system and its dysregulation in depressive illness , 2014, Molecular Psychiatry.

[72]  Robin M. Murray,et al.  Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis , 2010, Schizophrenia Research.

[73]  Martin Styner,et al.  Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type , 2013, Psychiatry Research: Neuroimaging.

[74]  S. Foley,et al.  Are symptoms associated with increased levels of perceived stress in first-episode psychosis? , 2009, International journal of mental health nursing.

[75]  E. Walker,et al.  Pubertal neuromaturation, stress sensitivity, and psychopathology , 2004, Development and Psychopathology.

[76]  S. Mednick,et al.  A multivariate prediction model of schizophrenia. , 2002, Schizophrenia bulletin.

[77]  Koen Van Laere,et al.  P.3.a.001 Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex , 2013, European Neuropsychopharmacology.

[78]  R. Murray,et al.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis , 2010, Psychological Medicine.

[79]  A. Malla,et al.  Family History of Schizophrenia and the Relationship of Stress to Symptoms: Preliminary Findings , 2001, The Australian and New Zealand journal of psychiatry.

[80]  S. Kapur,et al.  The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.

[81]  William P. Horan,et al.  Social anhedonia and schizotypy: The contribution of individual differences in affective traits, stress, and coping , 2007, Psychiatry Research.

[82]  M. Birchwood,et al.  Early intervention in psychosis: the critical-period hypothesis , 1998 .

[83]  L. Phillips,et al.  Stress and psychosis: towards the development of new models of investigation. , 2007, Clinical psychology review.

[84]  K. Nuechterlein,et al.  Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals , 2005, Schizophrenia Research.

[85]  R. Murray,et al.  Hypothalamic–pituitary–adrenal axis and clinical symptoms in first-episode psychosis , 2012, Psychoneuroendocrinology.

[86]  P. Sullivan,et al.  The Genetics of Schizophrenia , 2005, PLoS medicine.

[87]  Norio Ozaki,et al.  Adolescent Stress–Induced Epigenetic Control of Dopaminergic Neurons via Glucocorticoids , 2013, Science.

[88]  N. Afzal,et al.  Stress Axis Dysfunction: A Common Finding in Schizophrenia and the Metabolic Syndrome? , 2009 .

[89]  Patrick O. McGowan,et al.  Conserved epigenetic sensitivity to early life experience in the rat and human hippocampus , 2012, Proceedings of the National Academy of Sciences.

[90]  M. Gunnar,et al.  The neurobiology of stress and development. , 2007, Annual review of psychology.

[91]  M. Ponec,et al.  Glucocorticoid receptors. , 1993, Current problems in dermatology.

[92]  C. Pariante,et al.  HPA axis response to social stress is attenuated in schizophrenia but normal in depression: Evidence from a meta-analysis of existing studies , 2014, Neuroscience & Biobehavioral Reviews.

[93]  N. Nicolson,et al.  Hippocampal volume as marker of daily life stress sensitivity in psychosis , 2012, Psychological Medicine.

[94]  H. Westenberg,et al.  Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. , 2012, Schizophrenia bulletin.

[95]  U. Gschwandtner,et al.  Pituitary volume increase during emerging psychosis , 2011, Schizophrenia Research.

[96]  A. Malla,et al.  A prospective study of daily stressors and symptomatology in schizophrenic patients , 1994, Social Psychiatry and Psychiatric Epidemiology.

[97]  C. Gispen-de Wied Stress in schizophrenia: an integrative view. , 2000, European journal of pharmacology.

[98]  Heather C Whalley,et al.  Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms , 2002, British Journal of Psychiatry.

[99]  L. DeLisi,et al.  Reduced subicular subdivisions of the hippocampal formation and verbal declarative memory impairments in young relatives at risk for schizophrenia , 2013, Schizophrenia Research.

[100]  S. Kapur Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.

[101]  Hanneke E. Creemers,et al.  Alterations in HPA-axis and autonomic nervous system functioning in childhood anxiety disorders point to a chronic stress hypothesis , 2015, Psychoneuroendocrinology.

[102]  C. Pariante,et al.  Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: Relationship to psychosocial stress and cognition , 2014, Psychoneuroendocrinology.

[103]  I. Myin-Germeys,et al.  Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. , 2007, Clinical psychology review.

[104]  J. Os,et al.  Subtle Fluctuations in Psychotic Phenomena as Functional States of Abnormal Dopamine Reactivity in Individuals at Risk , 2005, Biological Psychiatry.

[105]  M. Keshavan,et al.  Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: A pilot study , 2007, Schizophrenia Research.

[106]  J. Pruessner,et al.  Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis , 2013, Schizophrenia Research.

[107]  K. Tessner,et al.  Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. , 2008, Annual review of clinical psychology.

[108]  B. McEwen,et al.  Effects of stress throughout the lifespan on the brain, behaviour and cognition , 2009, Nature Reviews Neuroscience.

[109]  Patricia Desmond,et al.  Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. , 2006, Archives of general psychiatry.

[110]  J. Read,et al.  Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies , 2012, Schizophrenia bulletin.

[111]  B. Misiak,et al.  Refining and integrating schizophrenia pathophysiology – Relevance of the allostatic load concept , 2014, Neuroscience & Biobehavioral Reviews.

[112]  J. Lieberman,et al.  Brain volume in first-episode schizophrenia , 2006, British Journal of Psychiatry.

[113]  P. Hofman,et al.  Pituitary volume, stress reactivity and genetic risk for psychotic disorder , 2011, Psychological Medicine.

[114]  Martin Styner,et al.  Hippocampal Shape and Volume Changes with Antipsychotics in Early Stage Psychotic Illness , 2012, Front. Psychiatry.

[115]  K. Laurens,et al.  Childhood adversity in schizophrenia: a systematic meta-analysis , 2012, Psychological Medicine.

[116]  A. Malla,et al.  Stressful Life Events and Schizophrenia II: Conceptual and Methodological Issues , 1993, British Journal of Psychiatry.

[117]  Jens C. Pruessner,et al.  Increased Stress-Induced Dopamine Release in Psychosis , 2012, Biological Psychiatry.

[118]  Larry J. Seidman,et al.  NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS CONSORTIUM: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS , 2008, Schizophrenia Research.

[119]  N. Pivac,et al.  Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients , 1999, Biological Psychiatry.

[120]  R. Murray,et al.  Pituitary volume in psychosis , 2004, British Journal of Psychiatry.

[121]  E. Walker,et al.  Stress and neurodevelopmental processes in the emergence of psychosis , 2013, Neuroscience.

[122]  R. Murray,et al.  Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder , 2008, Psychoneuroendocrinology.

[123]  T. Dinan,et al.  A systematic review of hypothalamic–pituitary–adrenal axis function in schizophrenia: implications for mortality , 2010, Journal of psychopharmacology.

[124]  NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS CONSORTIUM: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS , 2008, Schizophrenia Research.

[125]  J. Pearson,et al.  On the application of genetic expectancies as age-specific base rates in the study of human behavior disorders. , 1957, Psychological bulletin.

[126]  C. Pantelis,et al.  Stress and HPA-axis functioning in young people at ultra high risk for psychosis. , 2007, Journal of psychiatric research.

[127]  Glyn Lewis,et al.  Association between locus of control in childhood and psychotic symptoms in early adolescence: Results from a large birth cohort , 2011, Cognitive neuropsychiatry.

[128]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[129]  Peter B. Jones,et al.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review , 2007, The Lancet.

[130]  S. Dickerson,et al.  Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. , 2004, Psychological bulletin.

[131]  J. Os,et al.  The schizophrenia envirome , 2005, Current opinion in psychiatry.

[132]  E. Peters,et al.  Intrusions in trauma and psychosis: information processing and phenomenology , 2012, Psychological Medicine.

[133]  Bruce N Cuthbert,et al.  The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology , 2014, World psychiatry : official journal of the World Psychiatric Association.

[134]  K. Dedovic,et al.  Investigating the Association Between Early Life Parental Care and Stress Responsivity in Adulthood , 2010, Developmental neuropsychology.

[135]  The cortisol awakening response in caregivers of schizophrenic offspring shows sensitivity to patient status , 2011, Anxiety, stress, and coping.

[136]  P. McGuire,et al.  Blunted Cortisol Awakening Response in People at Ultra High Risk of Developing Psychosis , 2014, Schizophrenia Research.

[137]  G. Lewis,et al.  Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. , 2009, Archives of general psychiatry.

[138]  C. Nemeroff Structural Brain Alterations in Polysubstance Abusers , 1998 .

[139]  M. Keshavan,et al.  Grey matter and cognitive deficits in young relatives of schizophrenia patients , 2011, NeuroImage.

[140]  Godfrey D Pearlson,et al.  Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. , 2014, JAMA psychiatry.

[141]  Jens C. Pruessner,et al.  Dopamine Release in Response to a Psychological Stress in Humans and Its Relationship to Early Life Maternal Care: A Positron Emission Tomography Study Using [11C]Raclopride , 2004, The Journal of Neuroscience.

[142]  K H Nuechterlein,et al.  A heuristic vulnerability/stress model of schizophrenic episodes. , 1984, Schizophrenia bulletin.

[143]  R. Murray,et al.  Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment , 2010, Schizophrenia Research.

[144]  S. Kapur,et al.  Schizophrenia: more dopamine, more D2 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.